Health Care & Life Sciences » Pharmaceuticals | Whanin Pharmaceutical Co. Ltd.

Whanin Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
14,580
18,806
20,510
16,397
27,172
21,518
Depreciation, Depletion & Amortization
1,716
1,890
1,917
2,021
2,287
2,659
Other Funds
492
2,271
98
3,157
2,824
750
Funds from Operations
16,788
22,967
22,524
21,575
26,635
23,427
Changes in Working Capital
6,122
9,556
6,597
1,751
3,155
5,972
Net Operating Cash Flow
10,667
13,410
15,927
19,824
23,480
17,455
Capital Expenditures
1,230
11,938
3,350
7,462
19,313
Sale of Fixed Assets & Businesses
14
37
123
25
6
Purchase/Sale of Investments
11,311
7,463
2,108
181
19,231
Net Investing Cash Flow
12,653
17,567
548
6,848
37,482
Cash Dividends Paid - Total
3,817
3,817
3,817
3,817
3,817
Net Financing Cash Flow
3,817
3,817
3,817
3,817
3,817
Net Change in Cash
5,803
7,974
11,563
9,162
17,843
Free Cash Flow
9,510
1,482
13,586
12,401
4,352
Other Sources
241
1,978
674
1,176
1,197
Exchange Rate Effect
-
-
-
2
24
Other Uses
367
182
103
768
140

About Whanin Pharmaceutical Co.

View Profile
Address
Whanin Building
Seoul SL 05809
Korea, Republic Of
Employees -
Website http://www.whanin.com
Updated 07/08/2019
Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. Its products include psychotropic agent, medicine for circulating system and digestive ulcers, therapeutic for osteoporosis, pain killers, and others. The company was founded by Lee Kwang-Sik in June 1978 is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.